SEC Filings

Filing date	Form	Description	View
02/10/21	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-21-001542.pdf 0001179110-21-001542.rtf 0001179110-21-001542.xls
02/10/21	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-21-001543.pdf 0001179110-21-001543.rtf 0001179110-21-001543.xls
02/08/21	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000315066-21-001278.pdf 0000315066-21-001278.rtf
02/05/21	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000834237-21-007507.pdf 0000834237-21-007507.rtf
02/03/21	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000902219-21-000044.pdf 0000902219-21-000044.rtf 0000902219-21-000044.xls
01/11/21	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-21-002637.pdf 0001104659-21-002637.rtf 0001104659-21-002637.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
12/16/20	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-012003.pdf 0001179110-20-012003.rtf 0001179110-20-012003.xls
12/07/20	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-011737.pdf 0001179110-20-011737.rtf 0001179110-20-011737.xls
11/24/20	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-011363.pdf 0001179110-20-011363.rtf 0001179110-20-011363.xls
11/24/20	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-011367.pdf 0001179110-20-011367.rtf 0001179110-20-011367.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.

Shareholder Tools